ARCHIVES

Scope Of Panel’s Inquiry Outlined In Letter To Members

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

2018 State of Cancer Care in America

February 3, 2022